MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
-$16,688,000
EPS
-$0.2
Unit: Dollar
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Total revenue
0
0
0
0
Selling, general and administrative
5,216,000
6,290,000
5,866,000
5,201,000
Research and development
12,893,000
17,232,000
19,021,000
14,345,000
Restructuring charges
-
-
0
0
Cost of goods sold
0
0
0
0
Total operating expenses
18,109,000
23,522,000
24,887,000
19,546,000
Loss from operations
-18,109,000
-23,522,000
-24,887,000
-19,546,000
Gain on sale of business
0
0
0
-177,000
Foreign exchange loss
-6,000
-
9,500*
0
Other income
0
-
15,500*
127,000
Interest income
1,475,000
1,328,000
1,611,000
1,850,000
Interest expense
-
-
0*
0
Total other income (expense), net
1,469,000
1,328,000
1,636,000
1,800,000
Loss (income) before income tax expense
-16,640,000
-22,194,000
-23,251,000*
-
Income tax expense (benefit)
0
0
0*
-
Net (loss) income
-16,640,000
-22,194,000
-23,251,000
-17,746,000
Unrealized (gain) loss on investments, net of tax
-48,000
-135,000
-19,000
130,000
Comprehensive (loss) income
-16,688,000
-22,329,000
-23,270,000
-17,616,000
Basic EPS
-0.2
-0.32
-0.376
-0.26
Diluted EPS
-0.2
-0.32
-0.376
-0.26
Basic Average Shares
82,886,196
69,236,945
61,886,765*
69,204,899
Diluted Average Shares
82,886,196
69,236,945
61,886,765*
69,204,899
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Comprehensive (loss) income
-$16,688,000
(68.28%↑ Y/Y)
Net (loss) income
-$16,640,000
(68.37%↑ Y/Y)
Unrealized (gain) loss on
investments, net of tax
-$48,000
(-700.00%↓ Y/Y)
Interest income
$1,475,000
(-25.47%↓ Y/Y)
Loss (income) before
income tax expense
-$16,640,000
Total other income
(expense), net
$1,469,000
(-31.16%↓ Y/Y)
Foreign exchange loss
-$6,000
(-100.00%↓ Y/Y)
Loss from operations
-$18,109,000
(66.92%↑ Y/Y)
Total operating
expenses
$18,109,000
(-66.92%↓ Y/Y)
Research and development
$12,893,000
(-73.58%↓ Y/Y)
Selling, general and
administrative
$5,216,000
(-12.19%↓ Y/Y)
Buy us a coffee
Whitehawk Therapeutics, Inc. (WHWK)
Whitehawk Therapeutics, Inc. (WHWK)